Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Not Yet Recruiting

Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

NCT07151326

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chang-Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

China Medical University Hospital Taichung, Taiwan

National Cheng-Kung University Hospital Tainan, Taiwan

View Trial Details

Not Yet Recruiting

A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Lenvatinib and TACE for Advanced Hepatocellular Carcinoma

NCT07150377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA).

NCT07142876

Conditions: Abdominal Injuries, Adenocarcinoma, Carcinoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

NCT07131501

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Role of Long Noncoding RNA LINC01134 in Metastasis of Hepatitis C Virus-related Hepatocellular Carcinoma

NCT07130474

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

NCT07128251

Conditions: Adenocarcinoma, CTLA-4, Carcinoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

NCT07120750

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +25 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma

NCT07117279

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma

NCT07115550

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

NCT07109336

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details